Ammar Al-Chalabi, Kings College London, UK
Ammar Al-Chalabi is a consultant neurologist at King’s College Hospital, professor of neurology and complex disease genetics at the Maurice Wohl Clinical Neuroscience Institute at King’s College London, head of the department of Basic and Clinical Neuroscience, and director of the King’s Motor Neuron Disease Care and Research Centre. His research focuses on amyotrophic lateral sclerosis (ALS), also known as motor neuron disease. Al-Chalabi’s research team works on finding the causes of ALS and the factors that might influence the way the disease manifests and progresses, particularly where genes, environmental exposures, lifestyle, or changes in thinking and coping are involved. He runs a large clinical research programme that includes clinical trials. He leads or co-leads the Neurodegenerative Diseases Joint Programme, STRENGTH, BRAIN-MEND, and Project MinE consortia, which are large international collaborations that work to identify the causes of ALS, understand how different factors affect the disease course, and find new drug targets. Al-Chalabi is the recipient of several awards, including the Sheila Essey Award for ALS Research from the American Academy of Neurology and the ALS Association. He has held fellowships and exchange positions abroad at Massachusetts General Hospital, Harvard University, and Cold Spring Harbor Laboratory.
« Go Back